重庆山外山血液净化技术股份有限公司股东、董事及高级管理人员减持股份结果公告

Group 1 - The major shareholders, directors, and senior management of Chongqing Shanwaishan Blood Purification Technology Co., Ltd. have reduced their shareholdings as per the disclosed plan [2][3] - Before the reduction plan, the major shareholder Hunan Xiangjiang Liyuan Investment Management Co., Ltd. and its concerted action party held a total of 28,849,759 shares, accounting for approximately 8.98% of the company's total share capital [2] - The reduction plan was announced on September 12, 2025, and was set to be executed from October 14, 2025, to January 11, 2026, with adjustments made for any corporate actions during this period [3][4] Group 2 - During the reduction period, the major shareholder reduced their holdings by 85,661 shares, representing 0.03% of the current total share capital [3][4] - The director and senior management member Ren Yingxiang reduced his holdings by 248,265 shares, which is 0.08% of the current total share capital [4][6] - The total share capital of the company was adjusted to 319,600,622 shares for the calculation of the reduction percentages [6][7]